https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/70255-0025/
70255-0025 BRAFTOVI - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
ndc
https://pharma.economictimes.indiatimes.com/news/pharma-industry/pfizer-pushing-braf-lung-cancer-mutation-testing-to-grow-market-for-braftovi/113345734
Pfizer pushing BRAF lung cancer mutation testing to grow market for Braftovi, ETPharma
The company presented three-year follow-up data from a Phase 2 study on Saturday looking at patients with BRAF V600E-mutant metastatic non-small cell lung...